Pelvic inflammatory disease and ovarian cancer

Rafli van de Laar, R van de Laar, L.F.A.G. Massuger, L F Massuger
The Lancet. Oncology · 2011 · vol. 12(13) , pp. 1184 · doi:10.1016/s1470-2045(11)70352-7 · PMID:22123593 · W2023693567
Other OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-13 ⓘ

This paper examines the association between pelvic inflammatory disease (PID) and the risk of developing ovarian cancer.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Ovarian Neoplasms Pelvic Inflammatory Disease Female Humans Ovarian Neoplasms Pelvic Inflammatory Disease

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (7)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:09:44.076416+00:00
License: CC0 · commercial use OK